Pharming Group N.V. Rightofuse Assets
Pharming Group N.V. (PHAR) had Rightofuse Assets of $16.74 million as of 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Notes
ifrs-full:RightofuseAssets · last filed 2026-04-02
- 2020-12-31: Rightofuse Assets 7.68M EUR.
- 2019-12-31: Rightofuse Assets 5.98M EUR.
- 2019-01-01: Rightofuse Assets 4.79M EUR.
- 2018-12-31: Rightofuse Assets 4.79M EUR.
EUR
| Period end | Rightofuse Assets |
|---|---|
| 2020-12-31 | 7.68M EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 5.98M EUR 20-F · filed 2021-04-07 |
| 2019-01-01 | 4.79M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 4.79M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Rightofuse Assets |
|---|---|
| 2025-12-31 | $16.74M 20-F · filed 2026-04-02 |
| 2024-12-31 | $16.38M 20-F · filed 2026-04-02 |
| 2023-12-31 | $23.78M 20-F · filed 2025-04-03 |
| 2022-12-31 | $28.75M 20-F · filed 2024-04-04 |
| 2021-12-31 | $19.94M 20-F · filed 2024-04-04 |
| 2020-12-31 | $9.43M 20-F · filed 2023-04-05 |
| 2019-12-31 | $6.70M 20-F · filed 2022-04-06 |